Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.99% vs 10.55% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 105.75% vs -3,893.33% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 35.90% vs 168.08% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 104.00% vs 13.64% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Fuso Pharmaceutical Industries Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -17.57% vs 8.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.99% vs 10.55% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -61.66% vs 131.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 105.75% vs -3,893.33% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -56.65% vs 37.16% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 35.90% vs 168.08% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 27.50% vs 5.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 104.00% vs 13.64% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






